Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2011

Open Access 01-01-2011

Risk factors for ischemic stroke and transient ischemic attack in patients under age 50

Authors: A. W. M. Janssen, F. E. de Leeuw, M. C. H. Janssen

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2011

Login to get access

Abstract

To analyze risk factors for ischemic stroke and transient ischemic attack (TIA) in young adults under the age of 50. To make recommendations for additional research and practical consequences. From 97 patients with ischemic stroke or TIA under the age of 50, classical cardiovascular risk factors, coagulation disorders, history of migraine, use of oral contraceptives, cardiac abnormalities on ECG and echocardiography, and the results of duplex ultrasound were retrospectively analyzed. Literature was reviewed and compared to the results. 56.4% of the patients had hypertension, 12.1% increased total cholesterol, 20% hypertriglyceridemia, 31.5% an increased LDL-level, 32.6% a decreased HDL-level and 7.2% a disturbed glucose tolerance. Thrombophilia investigation was abnormal in 21 patients and auto-immune serology was abnormal in 15 patients. Ten of these patients were already known with a systemic disease associated with an increased risk for ischemic stroke (i.e. systemic lupus erythematosus). The ECG was abnormal in 16.7% of the cases, the echocardiography in 12.1% and duplex ultrasound of the carotid arteries was in 31.8% of the cases abnormal. Conventional cardiovascular risk factors are not only important in patients over the age of 50 with ischemic stroke or TIA, but also in this younger population under the age of 50. Thrombophilia investigation and/ or autoimmune serology should be restricted to patients without conventional cardiovascular risk factors and a history or other clinical symptoms associated with hypercoagulability and/ or autoimmune diseases.
Literature
1.
go back to reference Poos MJJC, van der Wilk EA. Sterfte naar doodsoorzaak samengevat. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. www.nationaalkompas.nl. Gezondheid en ziekte\ Sterfte, levensverwachting en DALY’s\ Sterfte naar doodsoorzaa. December 2008 Poos MJJC, van der Wilk EA. Sterfte naar doodsoorzaak samengevat. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. www.​nationaalkompas.​nl. Gezondheid en ziekte\ Sterfte, levensverwachting en DALY’s\ Sterfte naar doodsoorzaa. December 2008
2.
go back to reference Munts AG, van Genderen PJ, Dippel DW, van Kooten F, Koudstaal PJ (1998) Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 245:21–25CrossRefPubMed Munts AG, van Genderen PJ, Dippel DW, van Kooten F, Koudstaal PJ (1998) Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 245:21–25CrossRefPubMed
3.
go back to reference Kittner SJ, Stern BJ, Wozniak M, Buchholz DW, Earley CJ, Feeser BR, Johnson CJ, Macko RF, McCarter RJ, Price TR, Sherwin R, Sloan MA, Wityk RJ (1998) Cerebral infarction in young adults, the Baltimore-Washington cooperative young stroke study. Neurology 50:890–894PubMed Kittner SJ, Stern BJ, Wozniak M, Buchholz DW, Earley CJ, Feeser BR, Johnson CJ, Macko RF, McCarter RJ, Price TR, Sherwin R, Sloan MA, Wityk RJ (1998) Cerebral infarction in young adults, the Baltimore-Washington cooperative young stroke study. Neurology 50:890–894PubMed
4.
go back to reference Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, Godefroy O (2002) Clinical outcome in 287 consecutive young adults (15 tot 45 years) with ischemic stroke. Neurology 59:26–33PubMed Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, Godefroy O (2002) Clinical outcome in 287 consecutive young adults (15 tot 45 years) with ischemic stroke. Neurology 59:26–33PubMed
5.
go back to reference Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL (2006) Primary prevention of ischemic stroke. Stroke 37:1583–1633PubMed Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL (2006) Primary prevention of ischemic stroke. Stroke 37:1583–1633PubMed
6.
go back to reference Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Taklisumak T (2009) Analysis of 1008 consecutive patients aged 15 to 49 with firts-ever ischemic stroke. The Helsinki young stroke registry. Stroke 40:1195–1203CrossRefPubMed Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Taklisumak T (2009) Analysis of 1008 consecutive patients aged 15 to 49 with firts-ever ischemic stroke. The Helsinki young stroke registry. Stroke 40:1195–1203CrossRefPubMed
7.
go back to reference Rahemtullah A, van Cott EM (2007) Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med 131:890–901PubMed Rahemtullah A, van Cott EM (2007) Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med 131:890–901PubMed
8.
go back to reference Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI (2001) Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 32:1793–1799 Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI (2001) Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 32:1793–1799
9.
go back to reference Amiri M, Schmidley JW, Fink LM, Nazarian SM (2000) Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worth wile? Clin Neurol Neurosurg 102:219–222CrossRefPubMed Amiri M, Schmidley JW, Fink LM, Nazarian SM (2000) Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worth wile? Clin Neurol Neurosurg 102:219–222CrossRefPubMed
10.
go back to reference Aznar J, Mira Y, Vayá A, Corella D, Ferrando F, Villa P, Estellés A (2004) Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost 91:1031–1034PubMed Aznar J, Mira Y, Vayá A, Corella D, Ferrando F, Villa P, Estellés A (2004) Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost 91:1031–1034PubMed
11.
go back to reference Wu AHB, Tsongalis GJ (2001) Correlation of polymorphisms to coagulation, bichemical risk factors for cardiovascular diseases. Am J Cardiol 87:1361–1366CrossRefPubMed Wu AHB, Tsongalis GJ (2001) Correlation of polymorphisms to coagulation, bichemical risk factors for cardiovascular diseases. Am J Cardiol 87:1361–1366CrossRefPubMed
12.
go back to reference Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofoloate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146:948–957 Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofoloate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146:948–957
13.
go back to reference Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Meta-analysis of genetic studies in ischemic stroke. Arch Neurol 61:1652–1662CrossRefPubMed Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Meta-analysis of genetic studies in ischemic stroke. Arch Neurol 61:1652–1662CrossRefPubMed
14.
go back to reference Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G (2002) Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 33:51–56CrossRefPubMed Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G (2002) Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 33:51–56CrossRefPubMed
15.
go back to reference Longstreth WT Jr, Rosendaal FR, Siscovick DS, Vos HL, Schwartz SM, Psaty BM, Raghunathan TE, Koepsell TD, Reitsma PH (1998) Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 29:577–580PubMed Longstreth WT Jr, Rosendaal FR, Siscovick DS, Vos HL, Schwartz SM, Psaty BM, Raghunathan TE, Koepsell TD, Reitsma PH (1998) Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke 29:577–580PubMed
16.
go back to reference Zunker P, Hohenstein C, Plendl HJ, Zeller JA, Caso V, Georgiadis D, Allardt A, Deuschl G (2001) Activated protein C resistance and acute ischemic stroke: relation to stroke causation and age. J Neurol 248:701–704CrossRefPubMed Zunker P, Hohenstein C, Plendl HJ, Zeller JA, Caso V, Georgiadis D, Allardt A, Deuschl G (2001) Activated protein C resistance and acute ischemic stroke: relation to stroke causation and age. J Neurol 248:701–704CrossRefPubMed
17.
go back to reference Møller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jørgensen PE (2000) A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60:491–500CrossRefPubMed Møller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jørgensen PE (2000) A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60:491–500CrossRefPubMed
18.
go back to reference Bushnell CD, Goldstein LB (2000) Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31:3067–3078PubMed Bushnell CD, Goldstein LB (2000) Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31:3067–3078PubMed
19.
go back to reference Milhaud D, Bogousslavsky J, van Melle G, Liot P (2001) Ischemic stroke, active migraine. Neurology 57:1805–1811PubMed Milhaud D, Bogousslavsky J, van Melle G, Liot P (2001) Ischemic stroke, active migraine. Neurology 57:1805–1811PubMed
20.
go back to reference Moschiano F, D’Amico D, Ciusani E, Erba N, Rigamonti A, Schieroni F, Bussone G (2004) Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischemic stroke? Neurol Sci 25:S126–S128CrossRefPubMed Moschiano F, D’Amico D, Ciusani E, Erba N, Rigamonti A, Schieroni F, Bussone G (2004) Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischemic stroke? Neurol Sci 25:S126–S128CrossRefPubMed
21.
go back to reference Etminan M, Takkouche B, Caamaño Isorna F, Samii A (2005) Risk of ischaemic stroke in people with migraine: systemic review and meta-analysis of observational studies. BMJ 330:63CrossRefPubMed Etminan M, Takkouche B, Caamaño Isorna F, Samii A (2005) Risk of ischaemic stroke in people with migraine: systemic review and meta-analysis of observational studies. BMJ 330:63CrossRefPubMed
22.
go back to reference Chang CL, Donahy M, Poulter N (1999) Migraine, stroke in young women: case-control study. BMJ 318:13–18PubMed Chang CL, Donahy M, Poulter N (1999) Migraine, stroke in young women: case-control study. BMJ 318:13–18PubMed
23.
go back to reference Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK (2000) Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 31:1289–1293PubMed Ahmed E, Stegmayr B, Trifunovic J, Weinehall L, Hallmans G, Lefvert AK (2000) Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke 31:1289–1293PubMed
24.
go back to reference Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ (2002) Antiphospholipid antibodies and stroke in young women. Stroke 33:2396–2401CrossRefPubMed Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ (2002) Antiphospholipid antibodies and stroke in young women. Stroke 33:2396–2401CrossRefPubMed
25.
go back to reference Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 23:189–193PubMed Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 23:189–193PubMed
26.
go back to reference Urbanus RT, Siegerink B, Roest M, Rosendaal MR, de Groot PG, Algra A (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 8:998–1005CrossRefPubMed Urbanus RT, Siegerink B, Roest M, Rosendaal MR, de Groot PG, Algra A (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 8:998–1005CrossRefPubMed
27.
go back to reference Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. Committee, The APASS Writing (2004) JAMA 291:576–584 Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. Committee, The APASS Writing (2004) JAMA 291:576–584
28.
go back to reference Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chendru F, Guerin F, Bousser MG, de Recondo J (1993) Atrial septum aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24:1865–1873PubMed Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, Chendru F, Guerin F, Bousser MG, de Recondo J (1993) Atrial septum aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24:1865–1873PubMed
29.
go back to reference Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG (2007) Prothrombotic mutations as risk factor for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 38:2070–2073CrossRefPubMed Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG (2007) Prothrombotic mutations as risk factor for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 38:2070–2073CrossRefPubMed
30.
go back to reference Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M (2003) Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 14:261–268CrossRefPubMed Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M (2003) Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 14:261–268CrossRefPubMed
31.
go back to reference Belvís R, Santamaría A, Martí-Fàbregas J, Leta RG, Cocho D, Borrell M, Fontcuberta J, Martí-Vilalta JL (2007) Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis 18:537–542CrossRefPubMed Belvís R, Santamaría A, Martí-Fàbregas J, Leta RG, Cocho D, Borrell M, Fontcuberta J, Martí-Vilalta JL (2007) Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis 18:537–542CrossRefPubMed
32.
go back to reference Offelli P, Zanchetta M, Pedon L, Marzot F, Cucchini U, Pegoraro C, Iliceto S, Pengo V (2007) Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO). Thromb Haemost 98:906–907PubMed Offelli P, Zanchetta M, Pedon L, Marzot F, Cucchini U, Pegoraro C, Iliceto S, Pengo V (2007) Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO). Thromb Haemost 98:906–907PubMed
33.
go back to reference Rodés-Cabau J, Noël M, Marrero A, Rivest D, Mackey A, Houde C, Bédard E, Larose E, Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF (2009) Athersclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale. Stroke 40:419–425CrossRefPubMed Rodés-Cabau J, Noël M, Marrero A, Rivest D, Mackey A, Houde C, Bédard E, Larose E, Verreault S, Peticlerc M, Pibarot P, Bogaty P, Bertrand OF (2009) Athersclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale. Stroke 40:419–425CrossRefPubMed
34.
go back to reference Florez JC, Ay H, van Cott EM, Buonanno FS (2003) Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis 339:589–594 Florez JC, Ay H, van Cott EM, Buonanno FS (2003) Patent foramen ovale and hypercoagulability as combined risk factors for stroke. J Stroke Cerebrovasc Dis 339:589–594
37.
go back to reference Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE (1998) Stroke incidence among white. black, and hispanic residents of an urban community. Am J Epidemiol 147:259–268PubMed Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE (1998) Stroke incidence among white. black, and hispanic residents of an urban community. Am J Epidemiol 147:259–268PubMed
39.
go back to reference Lonn E (2007) Homocysteine in the prevention of ischemic heart disease, stroke, venous thromboembolism: therapeutic target or just another distraction? Curr Opin Hematol 14:481–487PubMed Lonn E (2007) Homocysteine in the prevention of ischemic heart disease, stroke, venous thromboembolism: therapeutic target or just another distraction? Curr Opin Hematol 14:481–487PubMed
40.
go back to reference Lonn E, Yusuf S, Phil D, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567–1577CrossRefPubMed Lonn E, Yusuf S, Phil D, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567–1577CrossRefPubMed
41.
go back to reference Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen J, Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578–1588CrossRefPubMed Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen J, Rasmussen K (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578–1588CrossRefPubMed
42.
go back to reference Bazzano LA, Reynolds K, Holder KN, He J (2006) Folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trial. JAMA 296:2720–2726CrossRefPubMed Bazzano LA, Reynolds K, Holder KN, He J (2006) Folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trial. JAMA 296:2720–2726CrossRefPubMed
43.
go back to reference Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E (2009) Homocysteine-lowering therapy and stroke risk. Severity, and disability; additional findings from the HOPE 2 trial. Stroke 40:1365–1372CrossRefPubMed Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E (2009) Homocysteine-lowering therapy and stroke risk. Severity, and disability; additional findings from the HOPE 2 trial. Stroke 40:1365–1372CrossRefPubMed
44.
go back to reference Nederkroon PJ, van der Graaf Y, Hunink MG (2003) Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systemic review. Stroke 34:1324–1332CrossRef Nederkroon PJ, van der Graaf Y, Hunink MG (2003) Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiography in carotid artery stenosis: a systemic review. Stroke 34:1324–1332CrossRef
Metadata
Title
Risk factors for ischemic stroke and transient ischemic attack in patients under age 50
Authors
A. W. M. Janssen
F. E. de Leeuw
M. C. H. Janssen
Publication date
01-01-2011
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2011
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-010-0491-3

Other articles of this Issue 1/2011

Journal of Thrombosis and Thrombolysis 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine